Iron overload is closely associated with metabolic dysfunction‐associated fatty liver disease in type 2 diabetes

Ähnliche Einträge

• Long‐term outcomes of metabolic surgery versus medical/lifestyle therapy on metabolic dysfunction‐associated fatty liver disease in adults with obesity and type 2 diabetes
  von: Michelle D. Lundholm, et al.
  Veröffentlicht: (2024)
• An interpretable machine learning model for predicting metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes
  von: Zhuolin Zhou, et al.
  Veröffentlicht: (2025)
• Associations between cuprotosis‐related genes and the spectrum of metabolic dysfunction‐associated fatty liver disease: An exploratory study
  von: Hai‐Yang Yuan, et al.
  Veröffentlicht: (2024)
• Glycaemic control metrics and metabolic dysfunction–associated steatotic liver disease in children and adolescents with type 1 diabetes
  von: Claudio Maffeis, et al.
  Veröffentlicht: (2024)
• Characterization of brain morphology associated with metabolic dysfunction‐associated steatotic liver disease in the UK Biobank
  von: Wenxiao Fan, et al.
  Veröffentlicht: (2025)